nodes	percent_of_prediction	percent_of_DWPC	metapath
Mannitol—ABCB1—ovarian cancer	0.534	1	CbGaD
Mannitol—ABCB1—Topotecan—ovarian cancer	0.101	0.354	CbGbCtD
Mannitol—ABCB1—Vinorelbine—ovarian cancer	0.0714	0.249	CbGbCtD
Mannitol—ABCB1—Paclitaxel—ovarian cancer	0.0501	0.175	CbGbCtD
Mannitol—ABCB1—Docetaxel—ovarian cancer	0.0362	0.127	CbGbCtD
Mannitol—ABCB1—Doxorubicin—ovarian cancer	0.027	0.0945	CbGbCtD
Mannitol—Renal failure—Docetaxel—ovarian cancer	0.000251	0.0014	CcSEcCtD
Mannitol—Stomatitis—Docetaxel—ovarian cancer	0.000249	0.00138	CcSEcCtD
Mannitol—Decreased appetite—Vinorelbine—ovarian cancer	0.000248	0.00138	CcSEcCtD
Mannitol—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000246	0.00137	CcSEcCtD
Mannitol—Cardiac failure congestive—Epirubicin—ovarian cancer	0.000246	0.00137	CcSEcCtD
Mannitol—Fatigue—Vinorelbine—ovarian cancer	0.000246	0.00137	CcSEcCtD
Mannitol—Hypersensitivity—Topotecan—ovarian cancer	0.000246	0.00137	CcSEcCtD
Mannitol—Pain—Vinorelbine—ovarian cancer	0.000244	0.00136	CcSEcCtD
Mannitol—Mediastinal disorder—Paclitaxel—ovarian cancer	0.000243	0.00135	CcSEcCtD
Mannitol—Chills—Paclitaxel—ovarian cancer	0.000242	0.00135	CcSEcCtD
Mannitol—Hypersensitivity—Melphalan—ovarian cancer	0.000241	0.00134	CcSEcCtD
Mannitol—Phlebitis—Doxorubicin—ovarian cancer	0.00024	0.00133	CcSEcCtD
Mannitol—Asthenia—Topotecan—ovarian cancer	0.000239	0.00133	CcSEcCtD
Mannitol—Thrombophlebitis—Doxorubicin—ovarian cancer	0.000239	0.00133	CcSEcCtD
Mannitol—Vomiting—Chlorambucil—ovarian cancer	0.000238	0.00133	CcSEcCtD
Mannitol—Diabetes mellitus—Doxorubicin—ovarian cancer	0.000237	0.00132	CcSEcCtD
Mannitol—Blood alkaline phosphatase increased—Doxorubicin—ovarian cancer	0.000237	0.00132	CcSEcCtD
Mannitol—Mental disorder—Paclitaxel—ovarian cancer	0.000237	0.00132	CcSEcCtD
Mannitol—Pruritus—Topotecan—ovarian cancer	0.000236	0.00131	CcSEcCtD
Mannitol—Malnutrition—Paclitaxel—ovarian cancer	0.000235	0.00131	CcSEcCtD
Mannitol—Feeling abnormal—Vinorelbine—ovarian cancer	0.000235	0.00131	CcSEcCtD
Mannitol—Asthenia—Melphalan—ovarian cancer	0.000234	0.0013	CcSEcCtD
Mannitol—Flatulence—Paclitaxel—ovarian cancer	0.000232	0.00129	CcSEcCtD
Mannitol—Pruritus—Melphalan—ovarian cancer	0.000231	0.00129	CcSEcCtD
Mannitol—Rhinitis—Docetaxel—ovarian cancer	0.000229	0.00128	CcSEcCtD
Mannitol—Cardiac failure—Epirubicin—ovarian cancer	0.000229	0.00127	CcSEcCtD
Mannitol—Nervousness—Paclitaxel—ovarian cancer	0.000228	0.00127	CcSEcCtD
Mannitol—Diarrhoea—Topotecan—ovarian cancer	0.000228	0.00127	CcSEcCtD
Mannitol—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.000228	0.00127	CcSEcCtD
Mannitol—Back pain—Paclitaxel—ovarian cancer	0.000227	0.00127	CcSEcCtD
Mannitol—Pharyngitis—Docetaxel—ovarian cancer	0.000227	0.00126	CcSEcCtD
Mannitol—Urticaria—Vinorelbine—ovarian cancer	0.000227	0.00126	CcSEcCtD
Mannitol—Urinary tract disorder—Docetaxel—ovarian cancer	0.000226	0.00126	CcSEcCtD
Mannitol—Body temperature increased—Vinorelbine—ovarian cancer	0.000225	0.00126	CcSEcCtD
Mannitol—Connective tissue disorder—Docetaxel—ovarian cancer	0.000225	0.00125	CcSEcCtD
Mannitol—Urethral disorder—Docetaxel—ovarian cancer	0.000224	0.00125	CcSEcCtD
Mannitol—Hyponatraemia—Epirubicin—ovarian cancer	0.000224	0.00125	CcSEcCtD
Mannitol—Diarrhoea—Melphalan—ovarian cancer	0.000223	0.00124	CcSEcCtD
Mannitol—Pain in extremity—Epirubicin—ovarian cancer	0.000223	0.00124	CcSEcCtD
Mannitol—Nausea—Chlorambucil—ovarian cancer	0.000222	0.00124	CcSEcCtD
Mannitol—Vision blurred—Paclitaxel—ovarian cancer	0.000222	0.00123	CcSEcCtD
Mannitol—Dizziness—Topotecan—ovarian cancer	0.00022	0.00123	CcSEcCtD
Mannitol—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000218	0.00121	CcSEcCtD
Mannitol—Vomiting—Topotecan—ovarian cancer	0.000212	0.00118	CcSEcCtD
Mannitol—Malaise—Paclitaxel—ovarian cancer	0.000212	0.00118	CcSEcCtD
Mannitol—Cardiac failure—Doxorubicin—ovarian cancer	0.000212	0.00118	CcSEcCtD
Mannitol—Vertigo—Paclitaxel—ovarian cancer	0.000211	0.00118	CcSEcCtD
Mannitol—Rash—Topotecan—ovarian cancer	0.00021	0.00117	CcSEcCtD
Mannitol—Hypersensitivity—Vinorelbine—ovarian cancer	0.00021	0.00117	CcSEcCtD
Mannitol—Dermatitis—Topotecan—ovarian cancer	0.00021	0.00117	CcSEcCtD
Mannitol—Headache—Topotecan—ovarian cancer	0.000209	0.00116	CcSEcCtD
Mannitol—Vomiting—Melphalan—ovarian cancer	0.000208	0.00116	CcSEcCtD
Mannitol—Dehydration—Epirubicin—ovarian cancer	0.000208	0.00116	CcSEcCtD
Mannitol—Hyponatraemia—Doxorubicin—ovarian cancer	0.000207	0.00115	CcSEcCtD
Mannitol—Pain in extremity—Doxorubicin—ovarian cancer	0.000206	0.00115	CcSEcCtD
Mannitol—Mediastinal disorder—Docetaxel—ovarian cancer	0.000206	0.00115	CcSEcCtD
Mannitol—Rash—Melphalan—ovarian cancer	0.000206	0.00115	CcSEcCtD
Mannitol—Dermatitis—Melphalan—ovarian cancer	0.000206	0.00114	CcSEcCtD
Mannitol—Chills—Docetaxel—ovarian cancer	0.000205	0.00114	CcSEcCtD
Mannitol—Cough—Paclitaxel—ovarian cancer	0.000205	0.00114	CcSEcCtD
Mannitol—Asthenia—Vinorelbine—ovarian cancer	0.000205	0.00114	CcSEcCtD
Mannitol—Abdominal pain upper—Epirubicin—ovarian cancer	0.000204	0.00113	CcSEcCtD
Mannitol—Convulsion—Paclitaxel—ovarian cancer	0.000204	0.00113	CcSEcCtD
Mannitol—Hypertension—Paclitaxel—ovarian cancer	0.000203	0.00113	CcSEcCtD
Mannitol—Pruritus—Vinorelbine—ovarian cancer	0.000202	0.00112	CcSEcCtD
Mannitol—Mental disorder—Docetaxel—ovarian cancer	0.000201	0.00112	CcSEcCtD
Mannitol—Arthralgia—Paclitaxel—ovarian cancer	0.0002	0.00111	CcSEcCtD
Mannitol—Chest pain—Paclitaxel—ovarian cancer	0.0002	0.00111	CcSEcCtD
Mannitol—Nasopharyngitis—Epirubicin—ovarian cancer	0.0002	0.00111	CcSEcCtD
Mannitol—Malnutrition—Docetaxel—ovarian cancer	0.000199	0.00111	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000199	0.00111	CcSEcCtD
Mannitol—Nausea—Topotecan—ovarian cancer	0.000198	0.0011	CcSEcCtD
Mannitol—Discomfort—Paclitaxel—ovarian cancer	0.000198	0.0011	CcSEcCtD
Mannitol—Diarrhoea—Vinorelbine—ovarian cancer	0.000195	0.00109	CcSEcCtD
Mannitol—Nausea—Melphalan—ovarian cancer	0.000194	0.00108	CcSEcCtD
Mannitol—Back pain—Docetaxel—ovarian cancer	0.000193	0.00107	CcSEcCtD
Mannitol—Dehydration—Doxorubicin—ovarian cancer	0.000192	0.00107	CcSEcCtD
Mannitol—Oedema—Paclitaxel—ovarian cancer	0.000192	0.00107	CcSEcCtD
Mannitol—Infection—Paclitaxel—ovarian cancer	0.000191	0.00106	CcSEcCtD
Mannitol—Dizziness—Vinorelbine—ovarian cancer	0.000189	0.00105	CcSEcCtD
Mannitol—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000189	0.00105	CcSEcCtD
Mannitol—Nervous system disorder—Paclitaxel—ovarian cancer	0.000188	0.00105	CcSEcCtD
Mannitol—Angina pectoris—Epirubicin—ovarian cancer	0.000188	0.00105	CcSEcCtD
Mannitol—Tachycardia—Paclitaxel—ovarian cancer	0.000187	0.00104	CcSEcCtD
Mannitol—Skin disorder—Paclitaxel—ovarian cancer	0.000186	0.00104	CcSEcCtD
Mannitol—Bronchitis—Epirubicin—ovarian cancer	0.000186	0.00103	CcSEcCtD
Mannitol—Nasopharyngitis—Doxorubicin—ovarian cancer	0.000185	0.00103	CcSEcCtD
Mannitol—Vomiting—Vinorelbine—ovarian cancer	0.000181	0.00101	CcSEcCtD
Mannitol—Rash—Vinorelbine—ovarian cancer	0.00018	0.001	CcSEcCtD
Mannitol—Dermatitis—Vinorelbine—ovarian cancer	0.00018	0.001	CcSEcCtD
Mannitol—Hypotension—Paclitaxel—ovarian cancer	0.000179	0.000998	CcSEcCtD
Mannitol—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000179	0.000998	CcSEcCtD
Mannitol—Headache—Vinorelbine—ovarian cancer	0.000179	0.000995	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000175	0.000973	CcSEcCtD
Mannitol—Cough—Docetaxel—ovarian cancer	0.000174	0.000968	CcSEcCtD
Mannitol—Angina pectoris—Doxorubicin—ovarian cancer	0.000174	0.000968	CcSEcCtD
Mannitol—Convulsion—Docetaxel—ovarian cancer	0.000173	0.000961	CcSEcCtD
Mannitol—Hypertension—Docetaxel—ovarian cancer	0.000172	0.000958	CcSEcCtD
Mannitol—Infestation NOS—Epirubicin—ovarian cancer	0.000172	0.000957	CcSEcCtD
Mannitol—Infestation—Epirubicin—ovarian cancer	0.000172	0.000957	CcSEcCtD
Mannitol—Bronchitis—Doxorubicin—ovarian cancer	0.000172	0.000955	CcSEcCtD
Mannitol—Dyspnoea—Paclitaxel—ovarian cancer	0.000171	0.000952	CcSEcCtD
Mannitol—Chest pain—Docetaxel—ovarian cancer	0.00017	0.000944	CcSEcCtD
Mannitol—Arthralgia—Docetaxel—ovarian cancer	0.00017	0.000944	CcSEcCtD
Mannitol—Nausea—Vinorelbine—ovarian cancer	0.000169	0.000943	CcSEcCtD
Mannitol—Renal failure—Epirubicin—ovarian cancer	0.000169	0.000941	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000168	0.000938	CcSEcCtD
Mannitol—Stomatitis—Epirubicin—ovarian cancer	0.000168	0.000933	CcSEcCtD
Mannitol—Decreased appetite—Paclitaxel—ovarian cancer	0.000167	0.000928	CcSEcCtD
Mannitol—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000166	0.000923	CcSEcCtD
Mannitol—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000166	0.000922	CcSEcCtD
Mannitol—Fatigue—Paclitaxel—ovarian cancer	0.000165	0.000921	CcSEcCtD
Mannitol—Pain—Paclitaxel—ovarian cancer	0.000164	0.000913	CcSEcCtD
Mannitol—Oedema—Docetaxel—ovarian cancer	0.000163	0.000905	CcSEcCtD
Mannitol—Infection—Docetaxel—ovarian cancer	0.000162	0.000899	CcSEcCtD
Mannitol—Nervous system disorder—Docetaxel—ovarian cancer	0.000159	0.000888	CcSEcCtD
Mannitol—Infestation NOS—Doxorubicin—ovarian cancer	0.000159	0.000886	CcSEcCtD
Mannitol—Infestation—Doxorubicin—ovarian cancer	0.000159	0.000886	CcSEcCtD
Mannitol—Tachycardia—Docetaxel—ovarian cancer	0.000159	0.000883	CcSEcCtD
Mannitol—Feeling abnormal—Paclitaxel—ovarian cancer	0.000158	0.00088	CcSEcCtD
Mannitol—Skin disorder—Docetaxel—ovarian cancer	0.000158	0.000879	CcSEcCtD
Mannitol—Renal failure—Doxorubicin—ovarian cancer	0.000156	0.000871	CcSEcCtD
Mannitol—Stomatitis—Doxorubicin—ovarian cancer	0.000155	0.000863	CcSEcCtD
Mannitol—Rhinitis—Epirubicin—ovarian cancer	0.000155	0.000862	CcSEcCtD
Mannitol—Pharyngitis—Epirubicin—ovarian cancer	0.000153	0.000853	CcSEcCtD
Mannitol—Urinary tract disorder—Epirubicin—ovarian cancer	0.000152	0.000849	CcSEcCtD
Mannitol—Urticaria—Paclitaxel—ovarian cancer	0.000152	0.000848	CcSEcCtD
Mannitol—Hypotension—Docetaxel—ovarian cancer	0.000152	0.000846	CcSEcCtD
Mannitol—Connective tissue disorder—Epirubicin—ovarian cancer	0.000152	0.000844	CcSEcCtD
Mannitol—Body temperature increased—Paclitaxel—ovarian cancer	0.000152	0.000844	CcSEcCtD
Mannitol—Urethral disorder—Epirubicin—ovarian cancer	0.000151	0.000842	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000148	0.000825	CcSEcCtD
Mannitol—Dyspnoea—Docetaxel—ovarian cancer	0.000145	0.000807	CcSEcCtD
Mannitol—Rhinitis—Doxorubicin—ovarian cancer	0.000143	0.000797	CcSEcCtD
Mannitol—Pharyngitis—Doxorubicin—ovarian cancer	0.000142	0.000789	CcSEcCtD
Mannitol—Decreased appetite—Docetaxel—ovarian cancer	0.000141	0.000787	CcSEcCtD
Mannitol—Hypersensitivity—Paclitaxel—ovarian cancer	0.000141	0.000787	CcSEcCtD
Mannitol—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000141	0.000785	CcSEcCtD
Mannitol—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00014	0.000781	CcSEcCtD
Mannitol—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00014	0.000781	CcSEcCtD
Mannitol—Fatigue—Docetaxel—ovarian cancer	0.00014	0.00078	CcSEcCtD
Mannitol—Urethral disorder—Doxorubicin—ovarian cancer	0.00014	0.000779	CcSEcCtD
Mannitol—Mediastinal disorder—Epirubicin—ovarian cancer	0.000139	0.000774	CcSEcCtD
Mannitol—Pain—Docetaxel—ovarian cancer	0.000139	0.000774	CcSEcCtD
Mannitol—Chills—Epirubicin—ovarian cancer	0.000139	0.000771	CcSEcCtD
Mannitol—Asthenia—Paclitaxel—ovarian cancer	0.000138	0.000766	CcSEcCtD
Mannitol—Pruritus—Paclitaxel—ovarian cancer	0.000136	0.000756	CcSEcCtD
Mannitol—Mental disorder—Epirubicin—ovarian cancer	0.000135	0.000753	CcSEcCtD
Mannitol—Malnutrition—Epirubicin—ovarian cancer	0.000134	0.000748	CcSEcCtD
Mannitol—Feeling abnormal—Docetaxel—ovarian cancer	0.000134	0.000746	CcSEcCtD
Mannitol—Flatulence—Epirubicin—ovarian cancer	0.000132	0.000737	CcSEcCtD
Mannitol—Diarrhoea—Paclitaxel—ovarian cancer	0.000131	0.000731	CcSEcCtD
Mannitol—Nervousness—Epirubicin—ovarian cancer	0.000131	0.000727	CcSEcCtD
Mannitol—Back pain—Epirubicin—ovarian cancer	0.00013	0.000724	CcSEcCtD
Mannitol—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000129	0.000717	CcSEcCtD
Mannitol—Body temperature increased—Docetaxel—ovarian cancer	0.000129	0.000716	CcSEcCtD
Mannitol—Chills—Doxorubicin—ovarian cancer	0.000128	0.000713	CcSEcCtD
Mannitol—Dizziness—Paclitaxel—ovarian cancer	0.000127	0.000706	CcSEcCtD
Mannitol—Vision blurred—Epirubicin—ovarian cancer	0.000127	0.000705	CcSEcCtD
Mannitol—Mental disorder—Doxorubicin—ovarian cancer	0.000125	0.000697	CcSEcCtD
Mannitol—Ill-defined disorder—Epirubicin—ovarian cancer	0.000125	0.000694	CcSEcCtD
Mannitol—Malnutrition—Doxorubicin—ovarian cancer	0.000124	0.000692	CcSEcCtD
Mannitol—Flatulence—Doxorubicin—ovarian cancer	0.000123	0.000682	CcSEcCtD
Mannitol—Vomiting—Paclitaxel—ovarian cancer	0.000122	0.000679	CcSEcCtD
Mannitol—Malaise—Epirubicin—ovarian cancer	0.000121	0.000675	CcSEcCtD
Mannitol—Rash—Paclitaxel—ovarian cancer	0.000121	0.000673	CcSEcCtD
Mannitol—Dermatitis—Paclitaxel—ovarian cancer	0.000121	0.000673	CcSEcCtD
Mannitol—Nervousness—Doxorubicin—ovarian cancer	0.000121	0.000672	CcSEcCtD
Mannitol—Vertigo—Epirubicin—ovarian cancer	0.000121	0.000672	CcSEcCtD
Mannitol—Back pain—Doxorubicin—ovarian cancer	0.00012	0.00067	CcSEcCtD
Mannitol—Headache—Paclitaxel—ovarian cancer	0.00012	0.000669	CcSEcCtD
Mannitol—Hypersensitivity—Docetaxel—ovarian cancer	0.00012	0.000667	CcSEcCtD
Mannitol—Cough—Epirubicin—ovarian cancer	0.000117	0.000653	CcSEcCtD
Mannitol—Vision blurred—Doxorubicin—ovarian cancer	0.000117	0.000652	CcSEcCtD
Mannitol—Asthenia—Docetaxel—ovarian cancer	0.000117	0.000649	CcSEcCtD
Mannitol—Convulsion—Epirubicin—ovarian cancer	0.000116	0.000648	CcSEcCtD
Mannitol—Hypertension—Epirubicin—ovarian cancer	0.000116	0.000646	CcSEcCtD
Mannitol—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000115	0.000642	CcSEcCtD
Mannitol—Pruritus—Docetaxel—ovarian cancer	0.000115	0.00064	CcSEcCtD
Mannitol—Chest pain—Epirubicin—ovarian cancer	0.000114	0.000637	CcSEcCtD
Mannitol—Arthralgia—Epirubicin—ovarian cancer	0.000114	0.000637	CcSEcCtD
Mannitol—Nausea—Paclitaxel—ovarian cancer	0.000114	0.000634	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000114	0.000632	CcSEcCtD
Mannitol—Discomfort—Epirubicin—ovarian cancer	0.000113	0.000629	CcSEcCtD
Mannitol—Malaise—Doxorubicin—ovarian cancer	0.000112	0.000624	CcSEcCtD
Mannitol—Vertigo—Doxorubicin—ovarian cancer	0.000112	0.000622	CcSEcCtD
Mannitol—Diarrhoea—Docetaxel—ovarian cancer	0.000111	0.000619	CcSEcCtD
Mannitol—Oedema—Epirubicin—ovarian cancer	0.00011	0.000611	CcSEcCtD
Mannitol—Infection—Epirubicin—ovarian cancer	0.000109	0.000607	CcSEcCtD
Mannitol—Cough—Doxorubicin—ovarian cancer	0.000109	0.000604	CcSEcCtD
Mannitol—Convulsion—Doxorubicin—ovarian cancer	0.000108	0.0006	CcSEcCtD
Mannitol—Nervous system disorder—Epirubicin—ovarian cancer	0.000108	0.000599	CcSEcCtD
Mannitol—Dizziness—Docetaxel—ovarian cancer	0.000108	0.000599	CcSEcCtD
Mannitol—Hypertension—Doxorubicin—ovarian cancer	0.000107	0.000598	CcSEcCtD
Mannitol—Tachycardia—Epirubicin—ovarian cancer	0.000107	0.000596	CcSEcCtD
Mannitol—Skin disorder—Epirubicin—ovarian cancer	0.000107	0.000593	CcSEcCtD
Mannitol—Arthralgia—Doxorubicin—ovarian cancer	0.000106	0.000589	CcSEcCtD
Mannitol—Chest pain—Doxorubicin—ovarian cancer	0.000106	0.000589	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000105	0.000585	CcSEcCtD
Mannitol—Discomfort—Doxorubicin—ovarian cancer	0.000105	0.000582	CcSEcCtD
Mannitol—Vomiting—Docetaxel—ovarian cancer	0.000103	0.000576	CcSEcCtD
Mannitol—Rash—Docetaxel—ovarian cancer	0.000103	0.000571	CcSEcCtD
Mannitol—Hypotension—Epirubicin—ovarian cancer	0.000102	0.00057	CcSEcCtD
Mannitol—Dermatitis—Docetaxel—ovarian cancer	0.000102	0.00057	CcSEcCtD
Mannitol—Headache—Docetaxel—ovarian cancer	0.000102	0.000567	CcSEcCtD
Mannitol—Oedema—Doxorubicin—ovarian cancer	0.000101	0.000565	CcSEcCtD
Mannitol—Infection—Doxorubicin—ovarian cancer	0.000101	0.000561	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Epirubicin—ovarian cancer	9.99e-05	0.000556	CcSEcCtD
Mannitol—Nervous system disorder—Doxorubicin—ovarian cancer	9.95e-05	0.000554	CcSEcCtD
Mannitol—Tachycardia—Doxorubicin—ovarian cancer	9.91e-05	0.000551	CcSEcCtD
Mannitol—Skin disorder—Doxorubicin—ovarian cancer	9.86e-05	0.000549	CcSEcCtD
Mannitol—Dyspnoea—Epirubicin—ovarian cancer	9.78e-05	0.000544	CcSEcCtD
Mannitol—Nausea—Docetaxel—ovarian cancer	9.66e-05	0.000538	CcSEcCtD
Mannitol—Decreased appetite—Epirubicin—ovarian cancer	9.54e-05	0.000531	CcSEcCtD
Mannitol—Hypotension—Doxorubicin—ovarian cancer	9.48e-05	0.000528	CcSEcCtD
Mannitol—Gastrointestinal disorder—Epirubicin—ovarian cancer	9.47e-05	0.000527	CcSEcCtD
Mannitol—Fatigue—Epirubicin—ovarian cancer	9.46e-05	0.000526	CcSEcCtD
Mannitol—Pain—Epirubicin—ovarian cancer	9.38e-05	0.000522	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	9.25e-05	0.000515	CcSEcCtD
Mannitol—Dyspnoea—Doxorubicin—ovarian cancer	9.05e-05	0.000504	CcSEcCtD
Mannitol—Feeling abnormal—Epirubicin—ovarian cancer	9.04e-05	0.000503	CcSEcCtD
Mannitol—Decreased appetite—Doxorubicin—ovarian cancer	8.82e-05	0.000491	CcSEcCtD
Mannitol—Gastrointestinal disorder—Doxorubicin—ovarian cancer	8.76e-05	0.000488	CcSEcCtD
Mannitol—Fatigue—Doxorubicin—ovarian cancer	8.75e-05	0.000487	CcSEcCtD
Mannitol—Urticaria—Epirubicin—ovarian cancer	8.71e-05	0.000485	CcSEcCtD
Mannitol—Pain—Doxorubicin—ovarian cancer	8.68e-05	0.000483	CcSEcCtD
Mannitol—Body temperature increased—Epirubicin—ovarian cancer	8.67e-05	0.000483	CcSEcCtD
Mannitol—Feeling abnormal—Doxorubicin—ovarian cancer	8.36e-05	0.000466	CcSEcCtD
Mannitol—Hypersensitivity—Epirubicin—ovarian cancer	8.08e-05	0.00045	CcSEcCtD
Mannitol—Urticaria—Doxorubicin—ovarian cancer	8.06e-05	0.000449	CcSEcCtD
Mannitol—Body temperature increased—Doxorubicin—ovarian cancer	8.02e-05	0.000447	CcSEcCtD
Mannitol—Asthenia—Epirubicin—ovarian cancer	7.87e-05	0.000438	CcSEcCtD
Mannitol—Pruritus—Epirubicin—ovarian cancer	7.76e-05	0.000432	CcSEcCtD
Mannitol—Diarrhoea—Epirubicin—ovarian cancer	7.5e-05	0.000418	CcSEcCtD
Mannitol—Hypersensitivity—Doxorubicin—ovarian cancer	7.48e-05	0.000416	CcSEcCtD
Mannitol—Asthenia—Doxorubicin—ovarian cancer	7.28e-05	0.000405	CcSEcCtD
Mannitol—Dizziness—Epirubicin—ovarian cancer	7.25e-05	0.000404	CcSEcCtD
Mannitol—Pruritus—Doxorubicin—ovarian cancer	7.18e-05	0.0004	CcSEcCtD
Mannitol—Vomiting—Epirubicin—ovarian cancer	6.97e-05	0.000388	CcSEcCtD
Mannitol—Diarrhoea—Doxorubicin—ovarian cancer	6.94e-05	0.000387	CcSEcCtD
Mannitol—Rash—Epirubicin—ovarian cancer	6.92e-05	0.000385	CcSEcCtD
Mannitol—Dermatitis—Epirubicin—ovarian cancer	6.91e-05	0.000385	CcSEcCtD
Mannitol—Headache—Epirubicin—ovarian cancer	6.87e-05	0.000382	CcSEcCtD
Mannitol—Dizziness—Doxorubicin—ovarian cancer	6.71e-05	0.000374	CcSEcCtD
Mannitol—Nausea—Epirubicin—ovarian cancer	6.52e-05	0.000363	CcSEcCtD
Mannitol—Vomiting—Doxorubicin—ovarian cancer	6.45e-05	0.000359	CcSEcCtD
Mannitol—Rash—Doxorubicin—ovarian cancer	6.4e-05	0.000356	CcSEcCtD
Mannitol—Dermatitis—Doxorubicin—ovarian cancer	6.39e-05	0.000356	CcSEcCtD
Mannitol—Headache—Doxorubicin—ovarian cancer	6.36e-05	0.000354	CcSEcCtD
Mannitol—Nausea—Doxorubicin—ovarian cancer	6.03e-05	0.000336	CcSEcCtD
